Information  X 
Enter a valid email address

Company Name matching 'Hyloris Pharmaceuticals'

Date
Time Source
Company
Announcement
07 Jul 2020 5:31 pm GNW   Hyloris Pharmaceuticals Mid-Stabilisation Period Announcement
06 Jul 2020 5:30 pm GNW   Hyloris Pharmaceuticals Publication of transparency notifications
30 Jun 2020 8:00 am GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals: Information on the total number of voting rights and shares – additional thresholds
26 Jun 2020 5:41 pm GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
24 Jun 2020 6:00 am GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
19 Jun 2020 5:10 pm GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option and Over-Allotment, at the Midpoint of the Price Range of its Initial Public Offering on Euronext Brussels
18 Jun 2020 4:03 pm GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of its Initial Public Offering on Euronext Brussels
17 Jun 2020 6:00 am GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
03 Jun 2020 6:00 am GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels
26 May 2020 6:00 am GNW   Hyloris Pharmaceuticals Hyloris appoints Patrick Jeanmart as Chief Financial Officer
30 Apr 2020 3:00 pm GNW   Hyloris Pharmaceuticals Hyloris Pharmaceuticals successfully raises €15 million in funding round


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t